Imunon, Inc.
IMNNNasdaqCIK 749647HealthcareFiscal year ends Dec 31
All transactions: 3
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-23 | Faller Douglas VincentChief Medical Officer, Officer | Grant or award | 1,092 | $1.235 | $1.3k | Form 4 |
| 2026-10-23 | Faller Douglas VincentChief Medical Officer, Officer | Grant or award | 26,741 | $1.235 | $33.0k | Form 4 |
| 2026-10-23 | Lindborg StacyPresident and CEO, Director, Officer | Grant or award | 2,603 | $1.235 | $3.2k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.